2012, Number 1
Next >>
Rev Hematol Mex 2012; 13 (1)
Haploidentical hematopoietic stem cell transplantation. Limit of incompatibility?
Tarín-Arzaga LC, González-Llano O
Language: Spanish
References: 14
Page: 1-3
PDF size: 53.10 Kb.
Text Extraction
No abstract
REFERENCES
Weisdorf DJ, Anasetti C, Antin JH, et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 2002;99:1971-1977.
Barker JN, Krepski TP, DeFor TE, et al. Searching for unrelated donor hematopoietic stem cell: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002;8:257-260.
Falk PM, Herzog P, Lubens R, et al. Bone marrow transplantation between a histocompatible parent and child for acute leukemia. Transplantation 1978;25:88-90.
Dupont B, O´Reilly RJ, Pollack MS and Good RA.Use of HLA genotypically different donors in bone marrow transplantation. Transplant Proc 1979;11:219-224.
Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation for related donors other than HLA-identical siblings. N Engl J Med 1985;313:765-771.
O´Reilly RJ, Kernan NA, Cunningham I, et al. Allogeneic transplants depleted of T cells by soybean lectin agglutination and E rosette depletion Bone Marrow Transplant 1988;3:3-6.
Aversa F, Terenzi A, Tabilio A, et al. Full haplotype-mismatched hematopoietic stem cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005; 23:3447-3454.
Bethge W, Faul C, Bornhauser M, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/ CD19 depletion and reduced intensity conditioning: an update. Blood Cells Mol Dis 2008;40:13-19.
O´Donnell PV, Luznik L, Jones RJ, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using postrasplantation cyclophosphamide. Biol Blod Marrow Transplant 2002;8:377-386.
Luznik L, O´Donnell P, Symons H, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using non-myeloablative conditioning and high-dose, postrasplantation cyclophosphamide. Biol Blood Marrow Transplant 2008;14:641-650.)
Brunstein CG, Fuchs EJ, Carter SL, et al. Alternative donor transplantation: results of paralel phase II trials using HLAmismatched related bone marrow or unrelated umbilical cord blood grafts. Blood 2011;118:282-288.
Huang XJ, Liu DH, Liu KY, et al. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant 2009;15:257-267.
Rizzieri DA, Koh LP, Long GD, et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 2007; 25:690-697.
Wang Y, Liu D-H, Xu L-P, et al. Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison. Biol Blood Marrow Transplant 2011;17:821-830.